The parkin V380L variant is a genetic modifier of Machado-Joseph disease with impact on mitophagy
Jonasz J Weber,Leah Czisch,Priscila Pereira Sena,Florian Fath,Chrisovalantou Huridou,Natasa Schwarz,Rana D Incebacak Eltemur,Anna Würth,Daniel Weishäupl,Miriam Döcker,Gunnar Blumenstock,Sandra Martins,Jorge Sequeiros,Guy A Rouleau,Laura Bannach Jardim,Maria-Luiza Saraiva-Pereira,Marcondes C França Jr,Carlos R Gordon,Roy Zaltzman,Mario R Cornejo-Olivas,Bart P C van de Warrenburg,Alexandra Durr,Alexis Brice,Peter Bauer,Thomas Klockgether,Ludger Schöls,Olaf Riess,EUROSCA Network,Thorsten Schmidt,José Berciano,Sylvia Boesch,Sylvie Forlani,Paola Giunti,Heike Jacobi,Bela Melegh,Massimo Pandolfo,Tanja Schmitz-Hübsch,Jörg B Schulz,Giovanni Stevanin,Sandra Szymanski,Sophie Tezenas du Montcel,Dagmar Timmann
DOI: https://doi.org/10.1007/s00401-024-02762-6
2024-08-01
Abstract:Machado-Joseph disease (MJD) is an autosomal dominant neurodegenerative spinocerebellar ataxia caused by a polyglutamine-coding CAG repeat expansion in the ATXN3 gene. While the CAG length correlates negatively with the age at onset, it accounts for approximately 50% of its variability only. Despite larger efforts in identifying contributing genetic factors, candidate genes with a robust and plausible impact on the molecular pathogenesis of MJD are scarce. Therefore, we analysed missense single nucleotide polymorphism variants in the PRKN gene encoding the Parkinson's disease-associated E3 ubiquitin ligase parkin, which is a well-described interaction partner of the MJD protein ataxin-3, a deubiquitinase. By performing a correlation analysis in the to-date largest MJD cohort of more than 900 individuals, we identified the V380L variant as a relevant factor, decreasing the age at onset by 3 years in homozygous carriers. Functional analysis in an MJD cell model demonstrated that parkin V380L did not modulate soluble or aggregate levels of ataxin-3 but reduced the interaction of the two proteins. Moreover, the presence of parkin V380L interfered with the execution of mitophagy-the autophagic removal of surplus or damaged mitochondria-thereby compromising cell viability. In summary, we identified the V380L variant in parkin as a genetic modifier of MJD, with negative repercussions on its molecular pathogenesis and disease age at onset.